Psagot Value Holdings Ltd. - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYESW and the CUSIP is 81362J118. A total of 10 filers reported holding SECOND SIGHT MED PRODS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Psagot Value Holdings Ltd. ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q1 2019$17,000
+70.0%
82,575
+113.6%
0.00%
Q4 2018$10,000
-66.7%
38,6530.0%0.00%
-100.0%
Q3 2018$30,000
+15.4%
38,6530.0%0.00%0.0%
Q2 2018$26,000
-18.8%
38,6530.0%0.00%0.0%
Q1 2018$32,0000.0%38,6530.0%0.00%0.0%
Q4 2017$32,000
+128.6%
38,6530.0%0.00%0.0%
Q3 2017$14,0000.0%38,6530.0%0.00%0.0%
Q2 2017$14,00038,6530.0%0.00%
Q1 2017$038,6530.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Anson Funds Management LP 1,337,580$2,568,0001.91%
Glassman Wealth Services 19,954$17,0000.01%
Psagot Value Holdings Ltd. 38,653$32,0000.00%
BNP PARIBAS FINANCIAL MARKETS 446,256$361,467,0000.00%
MORGAN STANLEY 443$00.00%
Financial Architects, Inc 1,406$1,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 394,717$339,0000.00%
UBS Group AG 6,047$5,0000.00%
IFP Advisors, Inc 692$1,0000.00%
NOMURA HOLDINGS INC 62,701$48,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders